Fungal biocompound discovery platform for sustainable ingredients
Mycolever is a biotech startup applying computational biology to fungal compound discovery. The stack—Python, Java, Nextflow, Neo4j, Databricks, cloud infrastructure—reflects a data-first R&D operation running high-throughput screening and validation pipelines. Hiring is balanced across product (3), engineering (1), and executive roles, with active recruiting for a Product Lead; the pain-point cluster (operational scalability, launch prep, go-to-market scaling, fundraising) points to a company in early-stage traction phase, moving from discovery into commercialization.
Notable leadership hires: Product Lead
Mycolever discovers and develops bioactive compounds derived from fungi for use in personal care, cosmetics, home care, and agriculture. Founded in 2023 and based in Rheinbach, Germany, the company operates a discovery platform that combines wet-lab screening with computational analysis to identify fungal-derived alternatives to synthetic ingredients. Current projects span biocompound discovery, high-throughput validation integration, product development, and go-to-market execution. The team is actively preparing for product launch and building out sales and operational infrastructure to move from R&D phase into customer delivery.
Python, Java, C++, SQL, Nextflow, Apache Airflow, Databricks, Neo4j, GCP, AWS, Azure, Docker, GitHub, and visualization tools (Plotly, Matplotlib, Bokeh) for bioinformatics and pipeline orchestration.
Biocompound discovery platform, high-throughput validation integration, product launch preparations, customer discovery services, go-to-market strategy, and operational scaling to move from R&D into commercialization.
Other companies in the same industry, closest in size